|
HURA TuHURA Biosciences Inc 1498382 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-9,223,298.00 |
| Balance Sheet |
|
Current Assets
|
$1,655,866.00 |
|
Assets
|
$31,746,253.00 |
|
Current Liabilities
|
$9,255,026.00 |
|
Liabilities
|
$13,245,793.00 |
|
Equity
|
$18,500,460.00 |
|
Shares Out
|
63682528.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-13,046,552.00 |
|
Investing Cash Flow
|
$-185,824.00 |
| Market Analysis |
Market Cap
|
$141,375,212.16 |
|
Price
|
$2.22 |
|
BVPS
|
0.29 |
|
PB
|
7.66 |
|
EPS
|
-0.14 |
|
FCF
|
$-29,246,552.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:49 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:39 |
|
| Apr |
May |
Jun |
| 2026-03-31 |
-0.63 |
|
|
2026-05-15 |
-0.13 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-14 |
-0.14 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view HURA documents filed with the SEC.
HURA Filings
Clear
